Claims for Patent: 5,653,958

Summary for Patent: 5,653,958

Title:	Imidazole based nitrogen-sulfur ligands useful in radiographic imaging agents
Abstract:	The present invention relates particularly to novel imidazole based nitrogen-sulfur ligands that are suitable for complexing with a radionuclide, and are useful as general imaging agents for diagnostic purposes.
Inventor(s):	Rajagopalan; Raghavan (Maryland Heights, MO), Srinivasan; Ananthachari (St. Charles, MO)
Assignee:	Mallinckrodt Medical, Inc. (St. Louis, MO)
Application Number:	08/419,319
Patent Claims:	1. A radionuclide complex having the general formula: ##STR16## wherein M represents an appropriate radionuclide; R.sup.1 is selected from the group consisting of hydrogen, alkyl, hydroxyl, alkoxyl, hydroxyalkyl, alkoxyalkyl, alkoxycarbonyl, or carbamoyl, wherein the carbon containing portions of such group contain 1 to 10 carbon atoms; L is selected from the group consisting of ##STR17## wherein k, l, m and n are 0 to 10, E is --O--, --S--, or --NR.sup.3, wherein R.sup.3 is defined in the same manner as R.sup.1 above, R.sup.4 is defined in the same manner as R.sup.1 above, and X is a suitable coupling moiety selected from the group consisting of formyl, carboxyl, hydroxyl, amino, t-butoxycarbonylamino, chlorocarbonyl, N-alkoxycarbamoyl, succinimidyloxycarbonyl, imidate, isocyanate, isothiocyanate, tetrafluorophenoxy, and the like; A is selected from the group consisting of ##STR18## wherein R.sup.5 to R.sup.7 are defined in the same manner as R.sup.1 above, and Y is defined in the same manner as L above; and B is selected from the group consisting of ##STR19## wherein R.sup.8 and R.sup.9 are defined in the same manner as R.sup.1 above, and Z is defined in the same manner as L above. 2. A complex according to claim 1, wherein M is technetium or rhenium. 3. A radiographic imaging agent comprising a complex having the general formula: ##STR20## wherein M represents an appropriate radionuclide; wherein R.sup.1 is hydrogen; L is hydrogen; A is ##STR21## wherein R.sup.5 and Y are hydrogen; and B is ##STR22## wherein R.sup.8 and Z are hydrogen; and a pharmaceutically acceptable vehicle. 4. An imaging agent according to claim 3, wherein said vehicle is suitable for injection or aspiration and is selected from the group consisting of human serum albumin, aqueous buffer solutions, sterile water, physiological saline, and balance ionic solutions containing chloride salts, dicarbonate salts or blood plasma cations. 5. An imaging agent according to claim 3, wherein M is technetium or rhenium. 6. An imaging agent according to claim 3, wherein the concentration of said complex in said vehicle is from about 1.0 to 50 millicuries. 7. A method of radiographic imaging, comprising injecting a sufficient amount of imaging agent to provide imaging and then scanning with a scanning machine; said imaging agent comprising a complex having the general formula: ##STR23## wherein M represents an appropriate radionuclide; wherein R.sup.1 is hydrogen; L is hydrogen; A is ##STR24## wherein R.sup.5 and Y are hydrogen; and B is ##STR25## wherein R.sup.8 and Z are hydrogen. 8. A method according to claim 7, wherein M is technetium or rhenium.

Details for Patent 5,653,958

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2014-08-05